International Conference On Orphan Drugs and Rare Diseases

August 8-10, 2022

August 08 -10, 2022 | Virtual Event

Orphan Drugs 2022

Speaker at Orphan Drugs and Rare Diseases 2022 - Harsha Rajasimha
Keynote Presentation
Harsha Rajasimha, Jeeva Informatics Solutions Inc, United States

Will be Updated Soon...

Speaker at Orphan Drugs and Rare Diseases 2022 - Candida Fratazzi
Keynote Presentation
Candida Fratazzi, BBCR Consulting - Massachusetts, United States

Will be Updated Soon...

Speaker at Orphan Drugs and Rare Diseases 2022 -  Daniel Scherman
Keynote Presentation
Daniel Scherman, Fondation Maladies Rares, France

The French rare disease research and clinical field has been a pioneer by structuring itself through different action plans. Competence centres and Reference centres are organized within  Rare Disease Health Networks (Filières de Santé Maladies Rares), which ha [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2022 - Magali Taiel
Oral Presentation
Magali Taiel, GenSight Biologics, France

Leber hereditary optic neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disease with a continued high unmet medical need. Three primary point mutations in the mtDNA are responsible for LHON in approximately 90% of subjects: G3460A, G11778A and T14484C, loca [....] » Read More

Speaker at Orphan Drugs and Rare Diseases 2022 -  Victor Shengkan jin
Keynote Presentation
Victor Shengkan jin, Rutgers University, United States

Will be Updated Soon...

Speaker at Orphan Drugs and Rare Diseases 2022 -  Jiao Fuyong
Keynote Presentation
Jiao Fuyong, Children’s Hospital of Shaanxi Provincial People’s Hospital, China

Kawasaki disease,It is a systemic vasioinflammatory disease in children of Asian descent,Coronary artery injury is its major complication,The disease has now become a major cause of acquired heart disease in children.The etiology of Kawasaki disease is not fully clear, and its pa [....] » Read More

Watsapp